Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
Capecitabine is a prescription medication used to treat breast cancer and cancer of the colon or rectum. Capecitabine belongs to a group of drugs called antimetabolites which work by interfering with DNA production, stopping cells from multiplying. The medication comes in tablet form and is usually taken twice daily, within 30 minutes after the end of a meal. Cancer clinical treatment projects have led to the increasing demand for Capecitabine. Increasing Cancer incidence across the globe, especially in the Asia-Pacific is another major factor, driving the growth of the Capecitabine market during the forecast period.
This report elaborates on the current development of the Capecitabine industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Cipla
Hikma
Teva
Mylan
Hengrui Medicine
Hetero
Reliance Group
By Type:
500 mg
150 mg
By Application:
Stomach Cancer
Colorectal Cancer
Breast Cancer
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Capecitabine Market Overview 2018-2029
-
1.1 China Capecitabine Industry Development Overview
-
1.2 China Capecitabine Industry Development History
-
1.3 China Capecitabine Industry Market Size (2018-2029)
-
1.4 China Capecitabine Market Analysis by Type from Production Side
-
1.4.1 China Capecitabine Production Volume, Production Value and Growth Rate of 500 mg (2018-2029)
-
1.4.2 China Capecitabine Production Volume, Production Value and Growth Rate of 150 mg (2018-2029)
-
1.5 China Capecitabine Market Analysis by Application from Consumption End
-
1.5.1 China Capecitabine Sales Volume, Sales Value and Growth Rate of Stomach Cancer (2018-2029)
-
1.5.2 China Capecitabine Sales Volume, Sales Value and Growth Rate of Colorectal Cancer (2018-2029)
-
1.5.3 China Capecitabine Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)
-
1.6 China Capecitabine Market Analysis by Region
-
1.6.1 North China Capecitabine Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Capecitabine Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Capecitabine Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Capecitabine Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Capecitabine Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Capecitabine Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Capecitabine Market Size and Growth Rate from 2018-2029
Chapter 2 China Capecitabine Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Capecitabine Market Status and Competition at home and abroad in 2023
-
2.2.2 China Capecitabine Market Status and Competition Analysis in 2023
-
2.2.3 China Capecitabine Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Capecitabine Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Capecitabine Industry Development
Chapter 3 CapecitabineIndustry Chain Analysis
-
3.1 Capecitabine Industry Chain
-
3.2 Capecitabine Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Capecitabine Market
-
3.3 Capecitabine Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Capecitabine Market
Chapter 4 China Capecitabine Market, by Type
-
4.1 China Capecitabine Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Capecitabine Total Production Volume and Growth Rate from Production Side
-
4.5 China Capecitabine Production Volume and Growth Rate, by Type
-
4.5.1 China Capecitabine Production Volume and Growth Rate of 500 mg
-
4.5.2 China Capecitabine Production Volume and Growth Rate of 150 mg
Chapter 5 China Capecitabine Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Capecitabine Total Market Size and Growth Rate from Consumption End
-
5.5 China Capecitabine Market Size and Growth Rate, by Application
-
5.5.1 China Capecitabine Market Size and Growth Rate of Stomach Cancer
-
5.5.2 China Capecitabine Market Size and Growth Rate of Colorectal Cancer
-
5.5.3 China Capecitabine Market Size and Growth Rate of Breast Cancer
Chapter 6 China Capecitabine Market, by Region
-
6.1 China Capecitabine Production Volume and Production Value, by Region
-
6.2 China Capecitabine Sales Volume and Sales Value, by Region
Chapter 7 North China Capecitabine Market Analysis
-
7.1 North China Capecitabine Market, by Type
-
7.2 North China Capecitabine Market, by Application
Chapter 8 Central China Capecitabine Market Analysis
-
8.1 Central China Capecitabine Market, by Type
-
8.2 Central China Capecitabine Market, by Application
Chapter 9 South China Capecitabine Market Analysis
-
9.1 South China Capecitabine Market, by Type
-
9.2 South China Capecitabine Market, by Application
Chapter 10 East China Capecitabine Market Analysis
-
10.1 East China Capecitabine Market, by Type
-
10.2 East China Capecitabine Market, by Application
Chapter 11 Northeast China Capecitabine Market Analysis
-
11.1 Northeast China Capecitabine Market, by Type
-
11.2 Northeast China Capecitabine Market, by Application
Chapter 12 Southwest China Capecitabine Market Analysis
-
12.1 Southwest China Capecitabine Market, by Type
-
12.2 Southwest China Capecitabine Market, by Application
Chapter 13 Northwest China Capecitabine Market Analysis
-
13.1 Northwest China Capecitabine Market, by Type
-
13.2 Northwest China Capecitabine Market, by Application
Chapter 14 Company Profiles
-
14.1 Cipla
-
14.1.1 Cipla Company Profile
-
14.1.2 Cipla Capecitabine Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Hikma
-
14.2.1 Hikma Company Profile
-
14.2.2 Hikma Capecitabine Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Teva
-
14.3.1 Teva Company Profile
-
14.3.2 Teva Capecitabine Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Mylan
-
14.4.1 Mylan Company Profile
-
14.4.2 Mylan Capecitabine Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Hengrui Medicine
-
14.5.1 Hengrui Medicine Company Profile
-
14.5.2 Hengrui Medicine Capecitabine Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Hetero
-
14.6.1 Hetero Company Profile
-
14.6.2 Hetero Capecitabine Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Reliance Group
-
14.7.1 Reliance Group Company Profile
-
14.7.2 Reliance Group Capecitabine Market Performance
-
14.7.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Capecitabine Industry Research Conclusions
-
15.2 Capecitabine Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Capecitabine Industry Market Size (2018-2029)
-
Figure China Capecitabine Production Volume, Production Value and Growth Rate of 500 mg (2018-2029)
-
Figure China Capecitabine Production Volume, Production Value and Growth Rate of 150 mg (2018-2029)
-
Figure China Capecitabine Sales Volume, Sales Value and Growth Rate of Stomach Cancer (2018-2029)
-
Figure China Capecitabine Sales Volume, Sales Value and Growth Rate of Colorectal Cancer (2018-2029)
-
Figure China Capecitabine Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)
-
Figure North China Capecitabine Market Size and Growth Rate from 2018-2029
-
Figure Central China Capecitabine Market Size and Growth Rate from 2018-2029
-
Figure South China Capecitabine Market Size and Growth Rate from 2018-2029
-
Figure East China Capecitabine Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Capecitabine Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Capecitabine Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Capecitabine Market Size and Growth Rate from 2018-2029
-
Figure Capecitabine Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Capecitabine Market Share by Type in 2018
-
Figure China Capecitabine Market Share by Type in 2023
-
Figure China Capecitabine Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Capecitabine Production Volume and Growth Rate of 500 mg (2018-2023)
-
Figure China Capecitabine Production Volume and Growth Rate of 150 mg (2018-2023)
-
Figure China Capecitabine Market Share by Application in 2018
-
Figure China Capecitabine Market Share by Application in 2023
-
Figure China Capecitabine Total Market Size and Growth Rate from Consumption End
-
Figure China Capecitabine Market Size and Growth Rate of Stomach Cancer (2018-2023)
-
Figure China Capecitabine Market Size and Growth Rate of Colorectal Cancer (2018-2023)
-
Figure China Capecitabine Market Size and Growth Rate of Breast Cancer (2018-2023)
-
Table China Capecitabine Production Volume by Region (2018-2023)
-
Table China Capecitabine Production Volume Share by Region (2018-2023)
-
Figure China Capecitabine Production Volume Share by Region (2018-2023)
-
Table China Capecitabine Production Value by Region (2018-2023)
-
Table China Capecitabine Production Value Share by Region (2018-2023)
-
Figure China Capecitabine Production Value Share by Region (2018-2023)
-
Table China Capecitabine Sales Volume by Region (2018-2023)
-
Table China Capecitabine Sales Volume Share by Region (2018-2023)
-
Figure China Capecitabine Sales Volume Share by Region (2018-2023)
-
Table China Capecitabine Sales Value by Region (2018-2023)
-
Table China Capecitabine Sales Value Share by Region (2018-2023)
-
Figure China Capecitabine Sales Value Share by Region (2018-2023)
-
Table North China Capecitabine Production Volume by Type (2018-2023)
-
Table North China Capecitabine Production Volume Share by Type (2018-2023)
-
Figure North China Capecitabine Production Volume Share by Type (2018-2023)
-
Table North China Capecitabine Sales Volume by Application (2018-2023)
-
Table North China Capecitabine Sales Volume Share by Application (2018-2023)
-
Figure North China Capecitabine Sales Volume Share by Application (2018-2023)
-
Table Central China Capecitabine Production Volume by Type (2018-2023)
-
Table Central China Capecitabine Production Volume Share by Type (2018-2023)
-
Figure Central China Capecitabine Production Volume Share by Type (2018-2023)
-
Table Central China Capecitabine Sales Volume by Application (2018-2023)
-
Table Central China Capecitabine Sales Volume Share by Application (2018-2023)
-
Figure Central China Capecitabine Sales Volume Share by Application (2018-2023)
-
Table South China Capecitabine Production Volume by Type (2018-2023)
-
Table South China Capecitabine Production Volume Share by Type (2018-2023)
-
Figure South China Capecitabine Production Volume Share by Type (2018-2023)
-
Table South China Capecitabine Sales Volume by Application (2018-2023)
-
Table South China Capecitabine Sales Volume Share by Application (2018-2023)
-
Figure South China Capecitabine Sales Volume Share by Application (2018-2023)
-
Table East China Capecitabine Production Volume by Type (2018-2023)
-
Table East China Capecitabine Production Volume Share by Type (2018-2023)
-
Figure East China Capecitabine Production Volume Share by Type (2018-2023)
-
Table East China Capecitabine Sales Volume by Application (2018-2023)
-
Table East China Capecitabine Sales Volume Share by Application (2018-2023)
-
Figure East China Capecitabine Sales Volume Share by Application (2018-2023)
-
Table Northeast China Capecitabine Production Volume by Type (2018-2023)
-
Table Northeast China Capecitabine Production Volume Share by Type (2018-2023)
-
Figure Northeast China Capecitabine Production Volume Share by Type (2018-2023)
-
Table Northeast China Capecitabine Sales Volume by Application (2018-2023)
-
Table Northeast China Capecitabine Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Capecitabine Sales Volume Share by Application (2018-2023)
-
Table Southwest China Capecitabine Production Volume by Type (2018-2023)
-
Table Southwest China Capecitabine Production Volume Share by Type (2018-2023)
-
Figure Southwest China Capecitabine Production Volume Share by Type (2018-2023)
-
Table Southwest China Capecitabine Sales Volume by Application (2018-2023)
-
Table Southwest China Capecitabine Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Capecitabine Sales Volume Share by Application (2018-2023)
-
Table Northwest China Capecitabine Production Volume by Type (2018-2023)
-
Table Northwest China Capecitabine Production Volume Share by Type (2018-2023)
-
Figure Northwest China Capecitabine Production Volume Share by Type (2018-2023)
-
Table Northwest China Capecitabine Sales Volume by Application (2018-2023)
-
Table Northwest China Capecitabine Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Capecitabine Sales Volume Share by Application (2018-2023)
-
Table Cipla Company Profile
-
Table Cipla Capecitabine Revenue, Price and Gross (2018-2023)
-
Table Hikma Company Profile
-
Table Hikma Capecitabine Revenue, Price and Gross (2018-2023)
-
Table Teva Company Profile
-
Table Teva Capecitabine Revenue, Price and Gross (2018-2023)
-
Table Mylan Company Profile
-
Table Mylan Capecitabine Revenue, Price and Gross (2018-2023)
-
Table Hengrui Medicine Company Profile
-
Table Hengrui Medicine Capecitabine Revenue, Price and Gross (2018-2023)
-
Table Hetero Company Profile
-
Table Hetero Capecitabine Revenue, Price and Gross (2018-2023)
-
Table Reliance Group Company Profile
-
Table Reliance Group Capecitabine Revenue, Price and Gross (2018-2023)
-
